molnupiravir

MERCK SELLS FEDERALLY FINANCED COVID PILL TO U.S. FOR 40 TIMES WHAT IT COSTS TO MAKE

The Intercept_ | by Sharon Lerner | October 5, 2021 The Covid-19 treatment molnupiravir was developed using funding from the National Institutes

4 years ago